This morning Slovenia-based startup AmblyoPlay released its new digital vision therapy platform aimed at helping individuals with amblyopia, commonly called “lazy eye.” The subscription-based ...
FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 / ...
Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co., LTD, a ...
A digital therapeutic (DTx) for amblyopia – sometimes known as lazy eye – has been shown to improve vision correction over standard therapy in a phase 3 trial, according to its developer Luminopia.
According to the final “ThemenCheck” report, no studies are available on non-digital vision training or vision training for other developmental vision disorders. Institute for Quality and Efficiency ...
In the "ThemenCheck Medizin" procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...
About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good. Although parents reported good adherence to therapy, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results